Oxford Immunotec Global PLC

CIK:0001586049|SEC Filings

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Revenue	$ 19,436,000	$ 21,219,000	$ 39,182,000	$ 55,596,000
Cost of revenue	4,578,000	5,731,000	10,352,000	15,359,000
Gross profit	14,858,000	15,488,000	28,830,000	40,237,000
Operating expenses:
Research and development	2,612,000	1,631,000	7,731,000	6,044,000
Sales and marketing	6,570,000	7,405,000	19,258,000	21,169,000
General and administrative	5,401,000	5,531,000	17,983,000	16,230,000
Settlement expense	0	799,000	0	1,002,000
Total operating expenses	14,583,000	15,366,000	44,972,000	44,445,000
Operating income (loss) from continuing operations	275,000	122,000	(16,142,000)	(4,208,000)
Other income (expense):
Interest income	65,000	1,064,000	770,000	3,426,000
Foreign exchange gains (losses)	(300,000)	360,000	539,000	(233,000)
Other income	18,000	23,000	50,000	65,000
Income (loss) from continuing operations before income taxes	58,000	1,569,000	(14,783,000)	(950,000)
Income tax benefit (expense) from continuing operations	(157,000)	(383,000)	(230,000)	1,230,000
Income (loss) from continuing operations	(99,000)	1,186,000	(15,013,000)	280,000
Discontinued operations:
Income (loss) from discontinued operations before income taxes	0	(469,000)	147,000	(469,000)
Income tax expense from discontinued operations	(50,000)	0	(995,000)	0
Loss from discontinued operations	(50,000)	(469,000)	(848,000)	(469,000)
Net income (loss)	$ (149,000)	$ 717,000	$ (15,861,000)	$ (189,000)
Net income (loss) per ordinary share - basic:
Income (loss) from continuing operations (in dollars per share)	$ 0	$ 0.04	$ (0.58)	$ 0.01
Loss from discontinued operations (in dollars per share)	0	(0.02)	(0.03)	(0.02)
Net income (loss) (in dollars per share)	(0.01)	0.03	(0.61)	(0.01)
Net income (loss) per ordinary share - diluted:
Income (loss) from continuing operations (in dollars per share)	0	0.04	(0.58)	0.01
Loss from discontinued operations (in dollars per share)	0	(0.02)	(0.03)	(0.02)
Net income (loss) (in dollars per share)	$ (0.01)	$ 0.03	$ (0.61)	$ (0.01)
Weighted-average shares used to compute net income (loss) per ordinary share - basic (in shares)	25,898,067	26,751,083	25,975,250	26,631,704
Weighted-average shares used to compute net income (loss) per ordinary share - diluted (in shares)	25,898,067	26,936,541	25,975,250	26,904,481